In The News Posted March 21, 2019 Share Posted March 21, 2019 PALO ALTO, Calif., March 21, 2019 /PRNewswire/ -- Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian (NYSE: VAR) hosted the first meeting of the FlashForward™ Consortium in Atlanta, Georgia on March 8-9. The two-day... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.